US4855231A
(en)
*
|
1984-10-30 |
1989-08-08 |
Phillips Petroleum Company |
Regulatory region for heterologous gene expression in yeast
|
US4885242A
(en)
*
|
1984-10-30 |
1989-12-05 |
Phillips Petroleum Company |
Genes from pichia histidine pathway and uses thereof
|
US4818700A
(en)
*
|
1985-10-25 |
1989-04-04 |
Phillips Petroleum Company |
Pichia pastoris argininosuccinate lyase gene and uses thereof
|
US4882279A
(en)
*
|
1985-10-25 |
1989-11-21 |
Phillips Petroleum Company |
Site selective genomic modification of yeast of the genus pichia
|
US4895800A
(en)
*
|
1985-11-26 |
1990-01-23 |
Phillips Petroleum Company |
Yeast production of hepatitis B surface antigen
|
ZA872534B
(en)
*
|
1986-05-08 |
1987-11-25 |
Phillips Petroleum Co |
Yeast production of streptokinase
|
US5258287A
(en)
*
|
1988-03-22 |
1993-11-02 |
Genentech, Inc. |
DNA encoding and methods of production of insulin-like growth factor binding protein BP53
|
IL89991A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Expression of hepatitis b pres2 protein in methylotrophic yeasts
|
IL89989A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Expression of human interleukin-2 in methylotrophic yeasts
|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
WO1990009434A1
(en)
*
|
1989-02-13 |
1990-08-23 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of superoxide dismutase in pichia pastoris yeast cells
|
US5254466A
(en)
*
|
1989-11-06 |
1993-10-19 |
Henkel Research Corporation |
Site-specific modification of the candida tropicals genome
|
US5612198A
(en)
*
|
1990-09-04 |
1997-03-18 |
The Salk Institute |
Production of insulin-like growth factor-1 in methylotrophic yeast cells
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
WO1992017595A1
(en)
*
|
1991-04-01 |
1992-10-15 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Genes which influence pichia proteolytic activity, and uses therefor
|
US6872550B1
(en)
*
|
1991-07-11 |
2005-03-29 |
Baxter Vaccine Ag |
Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
|
US5665600A
(en)
*
|
1991-09-18 |
1997-09-09 |
Research Corporation Technologies, Inc. |
Pichia pastoris linear plasmids and DNA fragments thereof
|
ATE246000T1
(de)
|
1992-06-03 |
2003-08-15 |
Genentech Inc |
Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
|
JP3541949B2
(ja)
*
|
1993-03-03 |
2004-07-14 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
メチロトローフ酵母におけるグリコレートオキシダーゼの製造
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
CA2202351A1
(en)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
WO1996012021A2
(en)
*
|
1994-10-18 |
1996-04-25 |
Corvas International, Inc. |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
DK0848755T4
(da)
|
1995-09-08 |
2011-05-23 |
Genentech Inc |
VEGF relateret protein
|
US5955349A
(en)
*
|
1996-08-26 |
1999-09-21 |
Zymogenetics, Inc. |
Compositions and methods for producing heterologous polypeptides in Pichia methanolica
|
US5716808A
(en)
*
|
1995-11-09 |
1998-02-10 |
Zymogenetics, Inc. |
Genetic engineering of pichia methanolica
|
WO1997017451A2
(en)
*
|
1995-11-09 |
1997-05-15 |
Zymogenetics, Inc. |
Production of gad65 in methylotrophic yeast
|
JP2000503204A
(ja)
|
1996-01-08 |
2000-03-21 |
ジェネンテック インコーポレーテッド |
Wsxレセプター及びリガンド類
|
US5854039A
(en)
*
|
1996-07-17 |
1998-12-29 |
Zymogenetics, Inc. |
Transformation of pichia methanolica
|
US5736383A
(en)
*
|
1996-08-26 |
1998-04-07 |
Zymogenetics, Inc. |
Preparation of Pichia methanolica auxotrophic mutants
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
CA2277266A1
(en)
|
1997-01-31 |
1998-08-06 |
Genentech, Inc. |
O-fucosyltransferase
|
US6100076A
(en)
|
1997-01-31 |
2000-08-08 |
Genentech, Inc. |
O-fucosyltransferase
|
WO1999021999A2
(en)
|
1997-10-29 |
1999-05-06 |
Genentech, Inc. |
Wnt-1 inducible genes
|
DE69829891T2
(de)
|
1997-04-07 |
2005-10-06 |
Genentech, Inc., South San Francisco |
Anti-VEGF Antikörper
|
DK0971959T3
(da)
|
1997-04-07 |
2006-05-15 |
Genentech Inc |
Humaniserede antistoffer og fremgangsmåder til dannelse af humaniserede antistoffer
|
US6265186B1
(en)
|
1997-04-11 |
2001-07-24 |
Dsm N.V. |
Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
ES2313756T3
(es)
|
1997-10-29 |
2009-03-01 |
Genentech, Inc. |
Usos de polipeptido secretado wisp-1 inducido por wnt-1.
|
EP2050762A3
(de)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Neue Polypeptide und für diese kodierende Nukleinsäuren
|
EP1865061A3
(de)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17-homologe Polypeptide und ihre therapeutische Verwendung
|
JP3577586B2
(ja)
|
1998-05-15 |
2004-10-13 |
ジェネンテック・インコーポレーテッド |
Il−17相同的ポリペプチドとその治療用途
|
EP3112468A1
(de)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17-homologe polypeptide und therapeutische verwendung davon
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US6316245B1
(en)
*
|
1998-09-16 |
2001-11-13 |
Biongene Co., Ltd. |
Mutant cells of Pichia
|
SI1135498T1
(sl)
|
1998-11-18 |
2008-06-30 |
Genentech Inc |
Variante protitelesa z višjo vezavno afiniteto vprimerjavi z izvirnimi protitelesi
|
CA2450402A1
(en)
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methods and compositions for inhibiting cancer cell growth comprising pro224
|
KR101077001B1
(ko)
|
1999-01-15 |
2011-10-26 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
US6720174B1
(en)
|
1999-01-28 |
2004-04-13 |
Novozymes A/S |
Phytases
|
DE60043367D1
(de)
|
1999-06-15 |
2009-12-31 |
Genentech Inc |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäuren zu deren Kodierung
|
KR100850389B1
(ko)
|
1999-06-25 |
2008-08-04 |
제넨테크, 인크. |
인간화 항-ErbB2 항체 및 항-ErbB2 항체를 사용한치료 방법
|
AU7878900A
(en)
*
|
1999-10-15 |
2001-04-30 |
Heska Corporation |
Method for production and use of mite group 1 proteins
|
EP1661996A1
(de)
|
1999-12-01 |
2006-05-31 |
Genentech, Inc. |
Sekretierte und transmembrane Polypeptide und dafür kodierende Nukleinsäuren
|
EP2163625B1
(de)
|
1999-12-23 |
2014-05-21 |
Genentech, Inc. |
IL-17 und IL-17R-homologe Polypeptide und ihre therapeutische Verwendung
|
WO2001077351A1
(en)
*
|
2000-04-07 |
2001-10-18 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Vectors and methods for dual protein expression in pichia pastoris and escherichia coli
|
JP2003531588A
(ja)
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
EP2275549A1
(de)
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
EP2077276A1
(de)
|
2000-06-23 |
2009-07-08 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
US7449308B2
(en)
*
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US7625756B2
(en)
*
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
DK1522590T3
(da)
*
|
2000-06-28 |
2009-12-21 |
Glycofi Inc |
Fremgangsmåde til fremstilling af modificerede glykoproteiner
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
DK1294910T3
(da)
|
2000-06-30 |
2009-03-02 |
Vib Vzw |
Protein glykosyleringsmodifikation i Pichia Pastoris
|
US7009045B2
(en)
*
|
2000-07-14 |
2006-03-07 |
Archer-Daniels-Midland Company |
Transformation systems for flavinogenic yeast
|
EP1303293B1
(de)
|
2000-07-27 |
2008-12-03 |
Genentech, Inc. |
Sequentielle verabreichung von cpt-11 und apo-2l polypeptid
|
EP2014298A3
(de)
|
2000-08-24 |
2009-10-07 |
Genentech, Inc. |
Interleukin-22-Polypeptide, Nukleinsäuren zu deren Codierung und Verfahren zur Behandlung von Bauchspeicheldrüsenerkrankungen
|
EP1944317A3
(de)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäure zu deren Kodierung
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
US7265208B2
(en)
|
2001-05-01 |
2007-09-04 |
The Regents Of The University Of California |
Fusion molecules and treatment of IgE-mediated allergic diseases
|
MXPA03010037A
(es)
|
2001-05-01 |
2004-06-30 |
Univ California |
Moleculas de fusion y metodos para tratamiento de enfermedades inmunes.
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100628425B1
(ko)
|
2001-06-20 |
2006-09-28 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
EP1427830B1
(de)
|
2001-08-29 |
2012-05-09 |
Genentech, Inc. |
Bv8-nukleinsäuren und polypeptide mit mitogener aktivität
|
NZ573742A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT212
|
US20030228319A1
(en)
|
2002-04-16 |
2003-12-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2067472A1
(de)
|
2002-01-02 |
2009-06-10 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
|
EP1575480A4
(de)
|
2002-02-22 |
2008-08-06 |
Genentech Inc |
Zusammensetzungen und verfahren zur behandlung von immunbedingten erkrankungen
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
US7705195B2
(en)
|
2002-06-07 |
2010-04-27 |
Genentech, Inc. |
Screening method
|
US7252933B2
(en)
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
HUP0600340A3
(en)
|
2002-07-15 |
2011-06-28 |
Genentech Inc |
Methods for identifying tumors that are responsive to treatment with anti-erbb2 antibodies
|
CA2496060C
(en)
|
2002-09-11 |
2015-08-04 |
Genentech, Inc. |
Protein purification by ion exchange chromatography
|
ATE493433T1
(de)
|
2002-09-11 |
2011-01-15 |
Genentech Inc |
Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
|
WO2004024072A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
CA2498274A1
(en)
|
2002-09-16 |
2004-03-25 |
Genentech, Inc. |
Compositions and methods for the diagnosis of immune related diseases using pro7
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
EP2322203A3
(de)
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Gestaltungen und methoden für die behandlung von Immune verwandte Krankheiten
|
AU2003295401B2
(en)
|
2002-11-08 |
2010-04-29 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP2311868A1
(de)
|
2002-11-26 |
2011-04-20 |
Genentech, Inc. |
Zusammensetzung und Verfahren zur Behandlung von Immunerkrankungen
|
KR20070055625A
(ko)
|
2002-12-16 |
2007-05-30 |
제넨테크, 인크. |
이뮤노글로불린 변이체 및 이들의 용도
|
ATE494367T1
(de)
*
|
2002-12-18 |
2011-01-15 |
Hoffmann La Roche |
Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
|
ATE387494T1
(de)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
Hitzelabile desoxyribonuklease i-varianten
|
CA2513113A1
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
MXPA05009743A
(es)
|
2003-03-12 |
2006-03-09 |
Genentech Inc |
Composiciones con actividad hematopoyetica e inmune.
|
EP1460425A1
(de)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Entglykosilierte Enzymen für Konjugaten
|
PL1610820T5
(pl)
|
2003-04-04 |
2014-01-31 |
Genentech Inc |
Preparaty zawierające wysokoskoncentrowane przeciwciała i białka
|
KR20160114727A
(ko)
|
2003-05-30 |
2016-10-05 |
제넨테크, 인크. |
항-vegf 항체를 사용한 치료
|
ATE525395T1
(de)
|
2003-06-12 |
2011-10-15 |
Lilly Co Eli |
Fusions proteine von glp-1-analoga
|
PT2784084T
(pt)
|
2003-07-08 |
2019-10-01 |
Genentech Inc |
Anticorpos antagonistas contra polipéptidos heterólogos il-17a/f
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7468267B2
(en)
|
2003-08-25 |
2008-12-23 |
Funzyme Biotechnologies Sa |
Fungal proteins and nucleic acids encoding same
|
PL2295073T3
(pl)
|
2003-11-17 |
2014-09-30 |
Genentech Inc |
Przeciwciało przeciwko CD22 do leczenia nowotworu pochodzącego z układu krwiotwórczego
|
DE602004025192D1
(de)
*
|
2003-12-05 |
2010-03-11 |
Roche Diagnostics Gmbh |
Rekombinante Carboxypeptidase B und ihre Aufreinigung
|
MXPA06007856A
(es)
|
2004-01-07 |
2007-03-23 |
Chiron Corp |
Anticuerpo monoclonal especifico de factor de estimulacion de colonias de macrofagos (m-csf) y usos del mismo.
|
CN1942584B
(zh)
|
2004-02-13 |
2011-07-27 |
诺维信公司 |
蛋白酶变体
|
KR100942849B1
(ko)
|
2004-03-30 |
2010-02-17 |
글락소 그룹 리미티드 |
면역글로불린
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
US20150017671A1
(en)
|
2004-04-16 |
2015-01-15 |
Yaping Shou |
Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
BRPI0513534A
(pt)
|
2004-07-20 |
2008-05-06 |
Genentech Inc |
inibidores de proteìna 4 semelhante à angiopoietina, combinações, e seu uso
|
JP5173428B2
(ja)
|
2004-11-10 |
2013-04-03 |
ディアデクサス インコーポレーテッド |
Ovr110抗体組成物および使用方法
|
EP1841793B1
(de)
|
2005-01-07 |
2010-03-31 |
Diadexus, Inc. |
Ovr110-antikörperzusammensetzungen und verwendungsverfahren dafür
|
NZ563341A
(en)
|
2005-06-06 |
2009-10-30 |
Genentech Inc |
Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
|
JP2009504183A
(ja)
|
2005-08-15 |
2009-02-05 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、それに関連する組成物および方法
|
EP1917363B1
(de)
|
2005-08-16 |
2011-06-22 |
Novo Nordisk A/S |
Verfahren zur herstellung reifer insulinpolypeptide
|
BRPI0616054B8
(pt)
*
|
2005-09-14 |
2021-05-25 |
Sanofi Aventis Deutschland |
processo para a preparação de insulina, um análogo de insulina ou um derivado de insulina, tripsina porcina, método para sua produção, dna e vetor
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
EA016245B9
(ru)
|
2005-11-18 |
2013-04-30 |
Гленмарк Фармасеутикалс С.А. |
Антитела против альфа2-интегрина и их применение
|
JP2009516514A
(ja)
|
2005-11-21 |
2009-04-23 |
ジェネンテック・インコーポレーテッド |
新規遺伝子破壊、それらに関する組成物および方法
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
JP2009527227A
(ja)
|
2006-02-17 |
2009-07-30 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、それに関連する組成物および方法
|
AU2007227224A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
NZ610566A
(en)
|
2006-04-05 |
2014-09-26 |
Abbvie Biotechnology Ltd |
Antibody purification
|
CA2647277A1
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
EP2027291A2
(de)
|
2006-04-27 |
2009-02-25 |
Pikamab, Inc. |
Verfahren und zusammensetzungen für antikörpertherapie
|
WO2007134327A2
(en)
|
2006-05-15 |
2007-11-22 |
Sea Lane Biotechnologies, Llc. |
Neutralizing antibodies to influenza viruses
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
AU2007261315B2
(en)
|
2006-06-21 |
2012-10-25 |
Musc Foundation For Research Development |
Targeting complement factor H for treatment of diseases
|
AU2007276294B2
(en)
|
2006-06-30 |
2012-11-29 |
Novo Nordisk A/S |
Anti-NKG2A antibodies and uses thereof
|
TWI454480B
(zh)
|
2006-08-18 |
2014-10-01 |
Novartis Ag |
催乳激素受體(prlr)之專一性抗體及其用途
|
JP5503968B2
(ja)
|
2006-09-27 |
2014-05-28 |
ノボ・ノルデイスク・エー/エス |
成熟インスリンポリペプチドの作製方法
|
CA2667706A1
(en)
|
2006-10-27 |
2008-05-08 |
Lpath, Inc. |
Compositions and methods for treating ocular diseases and conditions
|
PT2087002E
(pt)
|
2006-10-27 |
2014-11-26 |
Lpath Inc |
Composições e métodos para a ligação de esfingosina-1- fosfato
|
BRPI0716680A2
(pt)
|
2006-11-02 |
2013-09-24 |
Daniel J Capon |
"composto, multÍmero, composiÇço, mÉtodo de afetar a atividade de um alvo, complexo, processo de produÇço do composto, mÉtodo de produÇço de um extensço de aminoÁcidos consecutivos, processo de produÇço de uma extensço de aminoacidos consecutivos , processo para a produÇço de um composto , mÉtodo de produÇço de uma proteina e polipeptÍdeo"
|
WO2008061019A2
(en)
|
2006-11-14 |
2008-05-22 |
Genentech, Inc. |
Modulators of neuronal regeneration
|
JP5537946B2
(ja)
|
2006-11-22 |
2014-07-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Igf−irを含むチロシンキナーゼ受容体に対する改変タンパク質に基づく標的治療薬
|
EP2962697A1
(de)
|
2006-11-27 |
2016-01-06 |
diaDexus, Inc. |
Ovr110-antikörperzusammensetzungen und verfahren zur verwendung
|
US8288110B2
(en)
*
|
2006-12-04 |
2012-10-16 |
Perkinelmer Health Sciences, Inc. |
Biomarkers for detecting cancer
|
EP2101816B1
(de)
|
2006-12-07 |
2013-08-14 |
Novartis AG |
Antagonistische antikörper gegen ephb3
|
KR101431856B1
(ko)
|
2007-01-22 |
2014-08-27 |
제넨테크, 인크. |
항체의 고분자전해질 침전 및 정제
|
WO2008097497A2
(en)
|
2007-02-02 |
2008-08-14 |
Adnexus, A Bristol-Myers Squibb R & D Company |
Vegf pathway blockade
|
WO2008103962A2
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
KR101812400B1
(ko)
|
2007-04-03 |
2017-12-27 |
옥시레인 유케이 리미티드 |
분자의 글리코실화
|
EP2164992B1
(de)
|
2007-05-30 |
2016-05-04 |
Lpath, Inc. |
Zusammensetzungen und verfahren zur bindung von lysophosphatidinsäure
|
US9163091B2
(en)
|
2007-05-30 |
2015-10-20 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
KR101572700B1
(ko)
|
2007-06-07 |
2015-11-30 |
제넨테크, 인크. |
보체-관련 장애의 예방 및 치료를 위한 C3b 항체 및 방법
|
KR20190140090A
(ko)
|
2007-07-09 |
2019-12-18 |
제넨테크, 인크. |
폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
|
JP2010533495A
(ja)
|
2007-07-16 |
2010-10-28 |
ジェネンテック, インコーポレイテッド |
ヒト化CD79b抗体およびイムノコンジュゲートならびにそれらの使用
|
ATE543835T1
(de)
|
2007-07-16 |
2012-02-15 |
Genentech Inc |
Anti-cd79b-antikörper und immunkonjugate und anwendungsverfahren
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
US8361465B2
(en)
|
2007-10-26 |
2013-01-29 |
Lpath, Inc. |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
|
ES2572958T3
(es)
|
2007-10-30 |
2016-06-03 |
Genentech, Inc. |
Purificación de anticuerpos mediante cromatografía de intercambio catiónico
|
CA2704973A1
(en)
|
2007-11-08 |
2009-05-14 |
Genentech, Inc. |
Anti-factor b antibodies and their uses
|
CN104059143A
(zh)
|
2007-11-12 |
2014-09-24 |
特罗科隆科学有限公司 |
用于对流行性感冒进行治疗以及诊断的组合物以及方法
|
AR069501A1
(es)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
|
AR070141A1
(es)
|
2008-01-23 |
2010-03-17 |
Glenmark Pharmaceuticals Sa |
Anticuerpos humanizados especificos para el factor von willebrand
|
BRPI0908508A2
(pt)
|
2008-01-24 |
2016-03-22 |
Novo Nordisk As |
anticorpo monoclonal nkg2a anti-humano humanizado
|
ES2587392T3
(es)
|
2008-01-31 |
2016-10-24 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
JP5647009B2
(ja)
|
2008-03-03 |
2014-12-24 |
アッヴィ・インコーポレイテッド |
酵母を形質転換するための方法
|
WO2009114560A2
(en)
|
2008-03-10 |
2009-09-17 |
Spaltudaq Corporation |
Compositions and methods for the therapy and diagnosis of cytomegalovirus
|
AU2009228058A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
EP3208612B1
(de)
|
2008-04-09 |
2019-09-18 |
Genentech, Inc. |
Zusammensetzungen und verfahren zur behandlung von immunbedingten erkrankungen
|
CN104558151A
(zh)
|
2008-05-06 |
2015-04-29 |
健泰科生物技术公司 |
亲和力成熟的CRIg变体
|
EP3384919A1
(de)
|
2008-06-02 |
2018-10-10 |
Dana Farber Cancer Institute, Inc. |
Cs1-peptide
|
CN102149724B
(zh)
|
2008-08-14 |
2014-04-09 |
健泰科生物技术公司 |
使用原地蛋白质置换离子交换膜层析清除污染物的方法
|
WO2010034015A2
(en)
|
2008-09-22 |
2010-03-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
RU2520838C2
(ru)
|
2008-10-20 |
2014-06-27 |
Эббви Инк |
Выделение и очистка антител с использованием аффинной хроматографии на основе белка а
|
WO2010048446A2
(en)
|
2008-10-22 |
2010-04-29 |
Genentech, Inc. |
Modulation of axon degeneration
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
NZ592436A
(en)
|
2008-11-06 |
2012-10-26 |
Glenmark Pharmaceuticals Sa |
Treatment with anti-alpha2 integrin antibodies
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
WO2010078376A2
(en)
|
2008-12-30 |
2010-07-08 |
Ventana Medical Systems, Inc. |
Fc-specific polymer-conjugated antibodies and their diagnostic use
|
WO2010091122A1
(en)
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
NZ595574A
(en)
|
2009-04-01 |
2013-11-29 |
Genentech Inc |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
CN102459340A
(zh)
|
2009-04-23 |
2012-05-16 |
特罗科隆科学有限公司 |
粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体
|
CA2762302A1
(en)
|
2009-05-20 |
2010-11-25 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
CN106916229A
(zh)
|
2009-06-08 |
2017-07-04 |
阿穆尼克斯运营公司 |
生长激素多肽及其制备和使用方法
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
MX2012000705A
(es)
|
2009-07-15 |
2012-03-07 |
Abbott Lab |
Mejoramiento de produccion celular a traves de mecanotransduccion.
|
CA2769308A1
(en)
|
2009-07-31 |
2011-02-03 |
Genentech, Inc. |
Inhibition of tumor metastasis using bv8- or g-csf-antagonists
|
RU2571929C2
(ru)
|
2009-09-01 |
2015-12-27 |
Дженентек, Инк. |
Улучшенная очистка белка посредством модифицированного элюирования белка а
|
CA2772715C
(en)
|
2009-09-02 |
2019-03-26 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
CA2772945A1
(en)
|
2009-09-25 |
2011-03-31 |
Xoma Technology Ltd. |
Screening methods
|
EP2483399B1
(de)
|
2009-09-29 |
2019-03-27 |
Universiteit Gent |
Hydrolyse von mannose-1-phospho-mannose zu phospho-6-mannose
|
BR112012008907A2
(pt)
|
2009-10-15 |
2020-11-24 |
Genentech, Inc |
fatores de crescimento de fibroblastos quiméricos com especificidade receptora alterada
|
NZ599100A
(en)
|
2009-10-20 |
2014-07-25 |
Abbvie Inc |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
|
CN102711826B
(zh)
|
2009-10-22 |
2017-03-29 |
霍夫曼-拉罗奇有限公司 |
用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物
|
CN102573855A
(zh)
|
2009-10-22 |
2012-07-11 |
霍夫曼-拉罗奇有限公司 |
轴突变性的调节
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
US20110098862A1
(en)
|
2009-10-27 |
2011-04-28 |
ExxonMobil Research Engineering Company Law Department |
Multi-stage processes and control thereof
|
JP2013510871A
(ja)
|
2009-11-12 |
2013-03-28 |
ジェネンテック, インコーポレイテッド |
樹状突起棘の密度を促す方法
|
US20130053550A1
(en)
|
2009-11-19 |
2013-02-28 |
Oxyrane Uk Limited |
Yeast strains producing mammalian-like complex n-glycans
|
CA2781887C
(en)
|
2009-11-30 |
2018-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
WO2011080050A2
(en)
|
2009-12-11 |
2011-07-07 |
Novartis Ag |
Binding molecules
|
EP2509626B1
(de)
|
2009-12-11 |
2016-02-10 |
F.Hoffmann-La Roche Ag |
Anti-vegf-c-antikörper und verfahren zu ihrer verwendung
|
CN104193798A
(zh)
|
2009-12-18 |
2014-12-10 |
Csl有限公司 |
纯化多肽的方法
|
EP2515932A2
(de)
|
2009-12-21 |
2012-10-31 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Synergetische wirkung einer prolylprotease und tripeptidylproteasen
|
SG181834A1
(en)
|
2009-12-21 |
2012-07-30 |
Genentech Inc |
Antibody formulation
|
PE20121702A1
(es)
|
2010-01-28 |
2012-12-14 |
Glaxo Group Ltd |
Proteinas de enlace cd127
|
SG183335A1
(en)
|
2010-02-23 |
2012-09-27 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
RU2015102845A
(ru)
|
2010-02-23 |
2015-06-10 |
Санофи |
АНТИТЕЛА К ИНТЕГРИНУ α2 И ИХ ПРИМЕНЕНИЯ
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
AR081750A1
(es)
|
2010-03-31 |
2012-10-17 |
Boehringer Ingelheim Int |
Anticuerpos anti-cd40
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
PE20130460A1
(es)
|
2010-05-03 |
2013-04-26 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
CA2800728C
(en)
|
2010-05-28 |
2020-10-27 |
Genentech, Inc. |
Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
|
US9169329B2
(en)
|
2010-06-01 |
2015-10-27 |
Ludwig Institute For Cancer Research |
Antibodies directed to the receptor tyrosine kinase c-Met
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
US9405884B2
(en)
|
2010-06-16 |
2016-08-02 |
Abbvie Inc. |
Methods and systems for the analysis of protein samples
|
ES2690760T3
(es)
|
2010-06-25 |
2018-11-22 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Polipéptido de flagelina como agonista de TLR5 para su uso en el tratamiento de infecciones de las vías respiratorias
|
CN103108887A
(zh)
|
2010-07-22 |
2013-05-15 |
葛兰素史密丝克莱恩生物有限公司 |
新的抗原结合蛋白
|
EP2420250A1
(de)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4-Antikörper
|
US8900590B2
(en)
|
2010-08-12 |
2014-12-02 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
WO2012021773A1
(en)
|
2010-08-13 |
2012-02-16 |
Genentech, Inc. |
Antibodies to il-1beta and il-18, for treatment of disease
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
CA3201524A1
(en)
|
2010-08-31 |
2012-03-08 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
AU2011302522A1
(en)
|
2010-09-15 |
2013-05-02 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
NZ607750A
(en)
|
2010-09-20 |
2015-03-27 |
Abbvie Inc |
Purification of antibodies using simulated moving bed chromatography
|
CA2812870C
(en)
|
2010-09-29 |
2020-06-09 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
WO2012042387A2
(en)
|
2010-09-29 |
2012-04-05 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated n-glycans
|
US8481680B2
(en)
|
2010-10-05 |
2013-07-09 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US9632098B2
(en)
|
2010-10-08 |
2017-04-25 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments and uses thereof
|
WO2012045279A1
(en)
|
2010-10-08 |
2012-04-12 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments associated with immune thrombocytopenia
|
KR101708533B1
(ko)
|
2010-10-08 |
2017-02-20 |
상하이 켁신 바이오테크 씨오., 엘티디. |
재생불량 빈혈과 관련된 모에신 단편
|
EP2624854B1
(de)
|
2010-10-08 |
2016-08-03 |
Shanghai Kexin Biotech Co., Ltd |
Moesininhibitoren und ihre verwendungen
|
JP5913326B2
(ja)
|
2010-10-08 |
2016-04-27 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
モエシン断片の診断的および治療的使用
|
AP3953A
(en)
|
2010-11-04 |
2016-12-22 |
Boehringer Ingelheim Int |
Anti-IL-23 antibodies
|
AU2011338892A1
(en)
|
2010-11-05 |
2013-05-23 |
Abbvie Inc. |
Efficient and effective supplement screening for the development of chemically defined media in cell culture
|
NZ609567A
(en)
|
2010-11-05 |
2015-05-29 |
Transbio Ltd |
Markers of endothelial progenitor cells and uses thereof
|
WO2012064619A1
(en)
*
|
2010-11-10 |
2012-05-18 |
Merck Sharp & Dohme Corp. |
Pichia pastoris loci encoding enzymes in the proline biosynthetic pathway
|
US20140199682A1
(en)
|
2010-11-17 |
2014-07-17 |
Sea Lane Biotechnologies, Llc |
Influenza neutralizing agents
|
KR101941514B1
(ko)
|
2010-12-22 |
2019-01-23 |
테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 |
개선된 반감기를 가지는 변형된 항체
|
CN103687619A
(zh)
|
2011-02-14 |
2014-03-26 |
特罗科隆科学有限公司 |
用于对流行性感冒进行治疗以及诊断的组合物以及方法
|
CA2828347A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Bispecific three-chain antibody-like molecules
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
WO2012125735A1
(en)
|
2011-03-15 |
2012-09-20 |
Abott Laboratories |
An integrated approach to the isolation and purification of antibodies
|
CA2829968A1
(en)
|
2011-03-15 |
2012-09-20 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
JP6248029B2
(ja)
|
2011-03-31 |
2017-12-13 |
ジェネンテック, インコーポレイテッド |
ベータ7インテグリンアンタゴニストの投与方法
|
WO2012149197A2
(en)
|
2011-04-27 |
2012-11-01 |
Abbott Laboratories |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
CN107936121B
(zh)
|
2011-05-16 |
2022-01-14 |
埃泰美德(香港)有限公司 |
多特异性fab融合蛋白及其使用方法
|
EP2714735B1
(de)
|
2011-06-03 |
2021-07-21 |
XOMA Technology Ltd. |
Tgf-beta-spezifische antikörper
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
WO2013008171A1
(en)
|
2011-07-11 |
2013-01-17 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to ox40 and their uses
|
WO2013025944A1
(en)
|
2011-08-17 |
2013-02-21 |
Genentech, Inc. |
Inhibition of angiogenesis in refractory tumors
|
WO2013033069A1
(en)
|
2011-08-30 |
2013-03-07 |
Theraclone Sciences, Inc. |
Human rhinovirus (hrv) antibodies
|
AU2012311492A1
(en)
|
2011-09-23 |
2014-03-06 |
Amgen Research (Munich) Gmbh |
Bispecific binding molecules for 5T4 and CD3
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
KR102038310B1
(ko)
|
2011-11-16 |
2019-11-01 |
베링거 인겔하임 인터내셔날 게엠베하 |
항 il-36r 항체
|
EP2785744B1
(de)
|
2011-12-01 |
2017-10-04 |
AP Biosciences, Inc. |
Proteininhibitoren des komplementsystems und der vegf-signalwege sowie verfahren zu ihrer verwendung
|
CN104471068A
(zh)
|
2011-12-16 |
2015-03-25 |
布拉斯科南美公司(巴西) |
经修饰的微生物和使用其制造丁二烯的方法
|
SI2794635T1
(sl)
|
2011-12-22 |
2018-12-31 |
F. Hoffmann-La Roche Ag |
Ionskoizmenjevalna membranska kromatografija
|
WO2013091903A1
(en)
|
2011-12-22 |
2013-06-27 |
Novo Nordisk A/S |
Anti-crac channel antibodies
|
JP2015503338A
(ja)
|
2011-12-30 |
2015-02-02 |
オキシレイン ユーケー リミテッド |
組換えタンパク質の分解を低減させる方法および材料
|
US9951120B2
(en)
|
2012-01-19 |
2018-04-24 |
University Of Cincinnati |
Method of treating diabetes using non-glycosylated apolipoprotein A-IV
|
KR20140119777A
(ko)
|
2012-01-31 |
2014-10-10 |
제넨테크, 인크. |
항-ig-e m1'' 항체 및 그의 사용 방법
|
CA2864177C
(en)
|
2012-03-01 |
2019-11-26 |
Amgen Research (Munich) Gmbh |
Prolonged half-life albumin-binding protein fused bispecific antibodies
|
CA2867237C
(en)
|
2012-03-15 |
2024-01-02 |
Wouter Vervecken |
Methods and materials for treatment of pompe's disease
|
US9334319B2
(en)
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
WO2013158275A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Cell culture methods to reduce acidic species
|
CA2870769C
(en)
|
2012-04-27 |
2021-11-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vascular endothelial growth factor antagonists and methods for their use
|
CN109206516A
(zh)
|
2012-05-03 |
2019-01-15 |
勃林格殷格翰国际有限公司 |
抗IL-23p19抗体
|
US20140010820A1
(en)
|
2012-05-21 |
2014-01-09 |
Abbvie, Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
US9730980B2
(en)
|
2012-07-25 |
2017-08-15 |
University Of Cincinnati |
Method of treating type I diabetes using apolipoprotein A-IV
|
CA2878684A1
(en)
|
2012-07-25 |
2014-01-30 |
University Of Cincinnati |
Method of treating hyperglycemic disorders using apolipoprotein aiv
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
CN110787285A
(zh)
|
2012-11-05 |
2020-02-14 |
达纳-法伯癌症研究所股份有限公司 |
Xbp1、cd138和cs1肽、包括所述肽的药物组合物及使用所述肽和组合物的方法
|
EP2941302B1
(de)
|
2013-01-02 |
2018-08-01 |
Glenmark Pharmaceuticals S.A. |
An tl1a bindende antikörper und deren verwendungen
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
WO2014114801A1
(en)
|
2013-01-25 |
2014-07-31 |
Amgen Inc. |
Antibodies targeting cdh19 for melanoma
|
US20190040368A1
(en)
|
2013-03-05 |
2019-02-07 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
MY185551A
(en)
|
2013-03-13 |
2021-05-19 |
Genentech Inc |
Antibody formulations
|
WO2014160497A1
(en)
|
2013-03-13 |
2014-10-02 |
Genentech, Inc. |
Formulations with reduced oxidation
|
AR095398A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida
|
DK2968466T3
(en)
|
2013-03-13 |
2018-10-22 |
Hoffmann La Roche |
Reduced oxidation formulations
|
AR095399A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida, método
|
EP2970375A1
(de)
|
2013-03-14 |
2016-01-20 |
AbbVie Inc. |
Schwach saure zusammensetzungen und verfahren zu ihrer herstellung durch verdrängungschromatografie
|
US20140271633A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Mammalian cell culture performance through surfactant supplementation of feed media
|
WO2014142882A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Protein purification using displacement chromatography
|
CA2926301A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
Low acidic species compositions and methods for producing and using the same
|
WO2014140358A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Research (Munich) Gmbh |
Single chain binding molecules comprising n-terminal abp
|
EP2970875B1
(de)
|
2013-03-15 |
2020-04-15 |
F.Hoffmann-La Roche Ag |
Zellkulturzusammensetzungen mit antioxidanzien und verfahren zur herstellung von polypeptiden
|
EP3611180B1
(de)
|
2013-03-15 |
2021-12-22 |
Biomolecular Holdings LLC |
Hybrides immunglobulin mit nichtpeptidylverbindung
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res (Munich) Gmbh |
Moléculas de unión para bcma y cd3
|
US20140283157A1
(en)
|
2013-03-15 |
2014-09-18 |
Diadexus, Inc. |
Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
|
US9505849B2
(en)
|
2013-03-15 |
2016-11-29 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza M2 and CD3
|
US9441035B2
(en)
|
2013-03-15 |
2016-09-13 |
Genentech, Inc. |
Cell culture media and methods of antibody production
|
US10233249B2
(en)
|
2013-03-19 |
2019-03-19 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
SG11201507974RA
(en)
|
2013-03-27 |
2015-10-29 |
Genentech Inc |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
EA201592078A1
(ru)
|
2013-05-31 |
2016-04-29 |
Дженентек, Инк. |
Антитела против тейхоевых кислот клеточной стенки и их конъюгаты
|
CN105308067B
(zh)
|
2013-06-07 |
2020-07-24 |
诺和诺德股份有限公司 |
制备成熟胰岛素多肽的方法
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
AU2014324703C1
(en)
|
2013-09-27 |
2020-10-29 |
Genentech, Inc. |
Anti-PDL1 antibody formulations
|
WO2015069459A1
(en)
|
2013-11-05 |
2015-05-14 |
Novartis Ag |
Organic compounds
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
KR20240017102A
(ko)
|
2013-12-17 |
2024-02-06 |
제넨테크, 인크. |
Pd-1 축 결합 길항제 및 탁산을 이용한 암 치료 방법
|
JP2017501157A
(ja)
|
2013-12-17 |
2017-01-12 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及び抗cd20抗体を使用してがんを治療する方法
|
CA2934028A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
CN106062005A
(zh)
|
2013-12-30 |
2016-10-26 |
医药生命融合研究团 |
抗krs单克隆抗体及其用途
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
KR20160113715A
(ko)
|
2014-01-31 |
2016-09-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
신규한 항-baff 항체
|
WO2015120075A2
(en)
|
2014-02-04 |
2015-08-13 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
ES2788973T3
(es)
|
2014-03-14 |
2020-10-23 |
Biomolecular Holdings Llc |
Inmunoglobulina híbrida que contiene una unión distinta de peptidilo
|
KR102352250B1
(ko)
|
2014-03-25 |
2022-01-17 |
제넨테크, 인크. |
세포 배양 배지에 사용하기 위한 폴록사머를 제조하는 방법
|
MX2016012282A
(es)
|
2014-03-27 |
2017-01-06 |
Genentech Inc |
Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
|
JP6588461B2
(ja)
|
2014-03-31 |
2019-10-09 |
ジェネンテック, インコーポレイテッド |
抗血管新生剤及びox40結合アゴニストを含む併用療法
|
US8961992B1
(en)
|
2014-04-02 |
2015-02-24 |
Tunitas Therapeutics, Inc. |
Epsigam fusion protein
|
EP3149187B1
(de)
|
2014-05-30 |
2020-04-29 |
Braskem S.A. |
Modifizierte mikroorganismen mit einem optimierten system zur oligosaccharidnutzung und verfahren zur verwendung davon
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
WO2016004197A1
(en)
|
2014-07-03 |
2016-01-07 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
|
US20160185848A1
(en)
|
2014-07-09 |
2016-06-30 |
Abbvie Inc. |
Methods for modulating the glycosylation profile of recombinant proteins using sugars
|
EP3172339A1
(de)
|
2014-07-24 |
2017-05-31 |
Boehringer Ingelheim International GmbH |
Biomarker zur verwendung bei der behandlung von erkrankungen im zusammenhang mit il-23a
|
TW201609811A
(zh)
|
2014-07-31 |
2016-03-16 |
安美基研究(慕尼黑)公司 |
具有增強之組織分布之雙特異性單鏈抗體構築體
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
AR101936A1
(es)
|
2014-07-31 |
2017-01-25 |
Amgen Res (Munich) Gmbh |
Constructos de anticuerpos de cadena sencilla biespecífica específicos para especies cruzadas optimizadas
|
ES2949173T3
(es)
|
2014-09-15 |
2023-09-26 |
Hoffmann La Roche |
Formulaciones de anticuerpo
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
WO2016081384A1
(en)
|
2014-11-17 |
2016-05-26 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
KR20170086536A
(ko)
|
2014-12-03 |
2017-07-26 |
제넨테크, 인크. |
항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도
|
WO2016120764A1
(en)
|
2015-01-26 |
2016-08-04 |
Centre Hospitalier Universitaire Vaudois (Chuv) |
Aspergillus oryzae prolyl endopeptidases and use thereof in degradation of polypeptides
|
JP6758304B2
(ja)
|
2015-02-04 |
2020-09-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
炎症性疾患の処置法
|
US10330683B2
(en)
|
2015-02-04 |
2019-06-25 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
AR103782A1
(es)
|
2015-02-26 |
2017-05-31 |
Genentech Inc |
ANTAGONISTAS DE INTEGRINA b7 Y MÉTODOS DE TRATAMIENTO DE LA ENFERMEDAD DE CROHN
|
WO2016141111A1
(en)
|
2015-03-03 |
2016-09-09 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
WO2016144773A1
(en)
|
2015-03-06 |
2016-09-15 |
Abbvie Inc. |
Arabinosylated glycoproteins
|
WO2016161410A2
(en)
|
2015-04-03 |
2016-10-06 |
Xoma Technology Ltd. |
Treatment of cancer using inhibitors of tgf-beta and pd-1
|
MX2017013156A
(es)
|
2015-04-14 |
2018-02-21 |
Boehringer Ingelheim Int |
Metodos para tratar enfermedades.
|
ES2945313T3
(es)
|
2015-04-17 |
2023-06-30 |
Amgen Res Munich Gmbh |
Construcciones de anticuerpos biespecificos para CDH3 y CD3
|
CA2984638A1
(en)
|
2015-05-29 |
2016-12-08 |
Genentech, Inc. |
Pd-l1 promoter methylation in cancer
|
JP6896650B2
(ja)
|
2015-06-17 |
2021-06-30 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及びタキサンを使用した局所進行性または転移性乳癌の治療方法
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TW202340452A
(zh)
|
2015-08-04 |
2023-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
IL293385A
(en)
|
2015-08-11 |
2022-07-01 |
Omniab Inc |
New anti–pd–1 antibodies
|
US20190248905A1
(en)
|
2015-09-07 |
2019-08-15 |
Helmholtz Zentrum Muenchen-Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
Novel igfr-like receptor and uses thereof
|
TWI811716B
(zh)
|
2015-09-18 |
2023-08-11 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
US11040114B2
(en)
|
2015-12-24 |
2021-06-22 |
Oxyrane Uk Limited |
Human alpha-N-acetylgalactosaminidase polypeptide
|
BR112018010945A2
(pt)
|
2015-12-30 |
2018-12-04 |
Genentech Inc |
formulações com degradação de polissorbato reduzida
|
WO2017117304A1
(en)
|
2015-12-30 |
2017-07-06 |
Genentech, Inc. |
Use of tryptophan derivatives for protein formulations
|
EA201891753A1
(ru)
|
2016-02-03 |
2019-01-31 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкции антител к psma и cd3, вовлекающие т-клетки
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
UA126657C2
(uk)
|
2016-02-03 |
2023-01-11 |
Емджен Рісерч (Мюнік) Ґмбг |
ОДНОЛАНЦЮГОВА КОНСТРУКЦІЯ АНТИТІЛА ДО BCMA І CD3<font face="Symbol">e</font>
|
CN109071625A
(zh)
|
2016-02-04 |
2018-12-21 |
柯瑞斯公司 |
平滑化突变体和其使用方法
|
US10870701B2
(en)
|
2016-03-15 |
2020-12-22 |
Generon (Shanghai) Corporation Ltd. |
Multispecific fab fusion proteins and use thereof
|
AU2017235097B2
(en)
|
2016-03-15 |
2023-08-31 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
|
CN111363041B
(zh)
|
2016-03-23 |
2022-02-22 |
苏州创胜医药集团有限公司 |
新型抗-pd-l1抗体
|
CA3018794A1
(en)
|
2016-04-15 |
2017-10-19 |
Boehringer Ingelheim International Gmbh |
Use of il-23 antibodies for treating generalized pustular psoriasis
|
EP3442562B1
(de)
|
2016-04-15 |
2022-09-21 |
Evive Biotechnology (Shanghai) Ltd |
Ein il-22-dimer zur verwendung in der behandlung der nekrotisierenden enterokolitis
|
US10851159B2
(en)
|
2016-06-02 |
2020-12-01 |
Bloom Diagnostics Ag |
Antibodies that bind to human anti-Müllerian hormone (AMH) and their uses
|
EP3490600A1
(de)
|
2016-08-01 |
2019-06-05 |
Xoma (Us) Llc |
Parathormon-rezeptor 1 (pth1r)-antikörper und verwendungen davon
|
WO2018029124A1
(en)
|
2016-08-08 |
2018-02-15 |
F. Hoffmann-La Roche Ag |
Therapeutic and diagnostic methods for cancer
|
KR20190049866A
(ko)
|
2016-09-20 |
2019-05-09 |
우시 바이올로직스 아일랜드 리미티드 |
신규한 항-pcsk9 항체
|
KR20190057113A
(ko)
|
2016-09-28 |
2019-05-27 |
조마 (유에스) 엘엘씨 |
인터루킨-2에 결합하는 항체 및 그 용도
|
US20180105588A1
(en)
|
2016-10-14 |
2018-04-19 |
Boehringer Ingelheim International Gmbh |
Methods of treating diseases
|
US11007254B2
(en)
|
2016-10-17 |
2021-05-18 |
Musc Foundation For Research Development |
Compositions and methods for treating central nervous system injury
|
WO2018138376A1
(en)
|
2017-01-30 |
2018-08-02 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel igfr-like 2 receptor and uses thereof
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
EP4095161A1
(de)
|
2017-03-15 |
2022-11-30 |
Tsinghua University |
Neuartige anti-trkb-antikörper
|
JP2020512344A
(ja)
|
2017-03-27 |
2020-04-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗il−36r抗体併用治療
|
WO2018182284A1
(ko)
|
2017-03-27 |
2018-10-04 |
재단법인 의약바이오컨버젼스연구단 |
세포 외막에 노출되는 라이실-tRNA 합성효소 N-말단 영역에 특이적으로 결합하는 항체
|
EP3615569A1
(de)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antikörper und verfahren zur diagnose und behandlung von epstein-barr-virus-infektionen
|
BR112019022751A2
(pt)
|
2017-05-05 |
2020-05-19 |
Amgen Inc |
composição farmacêutica compreendendo construtos de anticorpos biespecíficos para armazenamento e administração melhorados
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
WO2019018629A1
(en)
|
2017-07-19 |
2019-01-24 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING INFECTION WITH HEPATITIS B VIRUS
|
AU2018326805B2
(en)
|
2017-09-01 |
2023-11-30 |
Dana-Farber Cancer Institute, Inc. |
Immunogenic peptides specific to BCMA and TACI antigens for treatment of cancer
|
WO2019089544A1
(en)
|
2017-11-01 |
2019-05-09 |
Tufts Medical Center, Inc. |
Bispecific antibody constructs and methods of use
|
BR112020011627A2
(pt)
|
2017-12-11 |
2020-11-17 |
Amgen Inc. |
processo de fabricação contínuo para produtos de anticorpos biespecíficos
|
UY38041A
(es)
|
2017-12-29 |
2019-06-28 |
Amgen Inc |
Construcción de anticuerpo biespecífico dirigida a muc17 y cd3
|
JP2021514193A
(ja)
|
2018-02-21 |
2021-06-10 |
セルジーン コーポレイション |
Bcma結合抗体及びその使用
|
KR102340989B1
(ko)
|
2018-03-28 |
2021-12-20 |
에이비온 주식회사 |
클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
|
EP3774916A2
(de)
|
2018-04-06 |
2021-02-17 |
Biolegend, Inc. |
Anti-tetraspanin-33-wirkstoffe und -zusammensetzungen und verfahren zur herstellung und verwendung davon
|
US20210171610A1
(en)
|
2018-05-02 |
2021-06-10 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
TWI819011B
(zh)
|
2018-06-23 |
2023-10-21 |
美商建南德克公司 |
以pd-1 軸結合拮抗劑、鉑劑及拓撲異構酶ii 抑制劑治療肺癌之方法
|
WO2020006347A1
(en)
|
2018-06-29 |
2020-01-02 |
Boehringer Ingelheim International Gmbh |
Anti-cd40 antibodies for use in treating autoimmune disease
|
WO2020033485A1
(en)
|
2018-08-08 |
2020-02-13 |
Genentech, Inc. |
Use of tryptophan derivatives and l-methionine for protein formulation
|
ES2955032T3
(es)
|
2018-09-21 |
2023-11-28 |
Hoffmann La Roche |
Métodos de diagnóstico para el cáncer de mama triple negativo
|
EP3856343A1
(de)
|
2018-09-25 |
2021-08-04 |
Biolegend, Inc. |
Anti-tlr9-mittel und zusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
|
TW202028239A
(zh)
|
2018-09-28 |
2020-08-01 |
美商安進公司 |
針對可溶性bcma之抗體
|
EP3863670A1
(de)
|
2018-10-11 |
2021-08-18 |
Amgen Inc. |
Downstream-verarbeitung von bispezifischen antikörperkonstrukten
|
CA3115887A1
(en)
|
2018-10-23 |
2020-04-30 |
Glycardial Diagnostics, S.L. |
Antibodies specific for glycosylated apoj and uses thereof
|
WO2020136232A1
(en)
|
2018-12-28 |
2020-07-02 |
Transgene Sa |
Immunosuppressive m2 protein
|
US20220118018A1
(en)
|
2019-03-06 |
2022-04-21 |
Dana-Farber Cancer Institute, Inc. |
T cell receptors specific to b-cell maturation antigen for treatment of cancer
|
EP3947441A1
(de)
|
2019-03-27 |
2022-02-09 |
UMC Utrecht Holding B.V. |
Manipulierte iga-antikörper und verfahren zur verwendung
|
CN113795509A
(zh)
|
2019-05-09 |
2021-12-14 |
勃林格殷格翰国际有限公司 |
抗-sema3a抗体及其用于治疗眼或眼部疾病的用途
|
KR20220012262A
(ko)
|
2019-05-24 |
2022-02-03 |
산유 바이오파마슈티컬스 씨오., 엘티디. |
신형 cldn18.2 결합분자
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
MX2022002337A
(es)
|
2019-08-27 |
2022-06-08 |
Tonix Pharma Ltd |
Polipéptidos de tff2 modificados.
|
AU2020345787A1
(en)
|
2019-09-10 |
2022-03-24 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein L capture dynamic binding capacity
|
WO2021054778A1
(ko)
|
2019-09-20 |
2021-03-25 |
경북대학교 산학협력단 |
Cox2 단백질의 아세틸화 검출용 항체 및 이의 용도
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
CA3156683A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
METHOD FOR REDUCING AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BI-SPECIFIC ANTIGEN-BINDING MOLECULES
|
US20230093169A1
(en)
|
2020-01-22 |
2023-03-23 |
Amgen Research (Munch) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CN113461817A
(zh)
|
2020-03-31 |
2021-10-01 |
苏州泽璟生物制药股份有限公司 |
一种抗人cd47抗体及其抗原结合片段、制备方法和应用
|
US20210371809A1
(en)
|
2020-04-15 |
2021-12-02 |
Genentech, Inc. |
Copper loss mitigation
|
BR112022023989A2
(pt)
|
2020-05-26 |
2023-02-07 |
Boehringer Ingelheim Int |
Anticorpos anti-pd-1
|
AR122493A1
(es)
|
2020-06-02 |
2022-09-14 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
WO2021257497A1
(en)
|
2020-06-15 |
2021-12-23 |
Sarepta Therapeutis, Inc. |
Adeno-associated virus antibodies and fragments thereof
|
WO2021257503A1
(en)
|
2020-06-16 |
2021-12-23 |
Genentech, Inc. |
Methods and compositions for treating triple-negative breast cancer
|
EP3939999A1
(de)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Antikörper zur neutralisierung der interleukin-11-rezeptor-alpha-unterheinheit (il11ra) und verwendungen davon
|
WO2022093640A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2c agents and compositions and methods for making and using the same
|
WO2022093641A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2a agents and compositions and methods for making and using the same
|
JP2023547662A
(ja)
|
2020-11-06 |
2023-11-13 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cldn6及びcd3に選択的に結合するポリペプチド構築物
|
JP2023548345A
(ja)
|
2020-11-06 |
2023-11-16 |
アムジエン・インコーポレーテツド |
クリッピング率の低減した抗原結合ドメイン
|
KR20230104229A
(ko)
|
2020-11-06 |
2023-07-07 |
암젠 인크 |
Cd3에 결합하는 폴리펩티드 구축물
|
CN112480248B
(zh)
|
2020-11-24 |
2023-05-05 |
三优生物医药(上海)有限公司 |
与cld18a2特异性结合的分子
|
AU2021401316A1
(en)
|
2020-12-18 |
2023-07-06 |
Kiniksa Pharmaceuticals, Ltd. |
Protein compositions and methods for producing and using the same
|
TW202313681A
(zh)
|
2021-04-02 |
2023-04-01 |
美商安進公司 |
Mageb2結合構建體
|
EP4332120A1
(de)
|
2021-04-26 |
2024-03-06 |
Xuanzhu Biopharmaceutical Co., Ltd. |
Bispezifisches antikörper-wirkstoff-konjugat
|
EP4373855A1
(de)
|
2021-07-23 |
2024-05-29 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Igfr-l1-antikörper und verwendungen davon
|
WO2023105087A1
(en)
|
2021-12-10 |
2023-06-15 |
Tubulis Gmbh |
Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors
|
EP4238988A1
(de)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antikörper gegen sars-cov-2 und verwendungen davon
|
WO2023173011A1
(en)
|
2022-03-09 |
2023-09-14 |
Bristol-Myers Squibb Company |
Transient expression of therapeutic proteins
|
WO2024032891A1
(en)
|
2022-08-11 |
2024-02-15 |
Vib Vzw |
Glyco-engineered yeast for therapeutic protein production
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|
WO2024083953A1
(en)
|
2022-10-18 |
2024-04-25 |
Tubulis Gmbh |
Novel anti-tpbg antibody and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof
|
US20240182596A1
(en)
|
2022-10-18 |
2024-06-06 |
Tubulis Gmbh |
Anti-napi2b antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof
|